Insight Molecular Diagnostics Inc.

Contributing Author

Recent Articles by Insight Molecular Diagnostics Inc.

1 hour	Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing IMDX -7.13% GlobeNewswire
Aug-10	IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx IMDX GlobeNewswire
Aug-04	iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference IMDX GlobeNewswire
Jul-23	iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication IMDX GlobeNewswire
Jul-16	Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio IMDX GlobeNewswire
Jun-29	IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper IMDX GlobeNewswire
Jun-22	iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant IMDX GlobeNewswire
Jun-16	Favorable Head-to-Head Data on iMDx's GraftAssure with Competing NGS Assay Published in Clinical Chemistry IMDX -6.67% GlobeNewswire
Jun-11	IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation IMDX -5.73% GlobeNewswire
Jun-09	iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress IMDX GlobeNewswire
May-13	IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization IMDX IMDX +25.88% GlobeNewswire
May-06	iMDx to Release First Quarter 2026 Results on May 13, 2026 IMDX +9.83% GlobeNewswire
Apr-14	Real-World Evidence and Industry Momentum Builds for iMDx's Flagship GraftAssure Assay IMDX +20.33% GlobeNewswire
Mar-26	IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results IMDX IMDX -13.38% GlobeNewswire
Mar-20	iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference IMDX +8.67% GlobeNewswire
Mar-13	Second Study Affirms Superiority of iMDx GraftAssure Assay's Proprietary dd-cfDNA Combination Model Score IMDX GlobeNewswire
Mar-03	Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission IMDX +10.32% GlobeNewswire
Feb-11	iMDx Announces $26.0 Million Registered Direct Offering IMDX -22.67% GlobeNewswire
Jan-13	IMDX Supports AST and ASHI STAR Working Group's Call for Decentralized Transplant Monitoring IMDX GlobeNewswire
Jan-07	iMDx Announces "JPM Week" and "BTIG Snowbird" Conference Participation IMDX GlobeNewswire
Jan-06	iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch IMDX GlobeNewswire
Jan-05	iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion IMDX GlobeNewswire
Nov-10	IMDX Reports Q3 2025 Results and Progress Toward 2026 Commercial Launch IMDX +8.97% IMDX +10.66% GlobeNewswire
Nov-03	iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week IMDX GlobeNewswire
Oct-13	iMDx Welcomes New VP Marketing to Prepare for Commercial Transplant Assay Launch IMDX GlobeNewswire
Oct-06	iMDx Reports Kidney Transplant Patient Achieved 'Immune Reset' with Novel Therapy and GraftAssure Monitoring IMDX GlobeNewswire
Sep-24	Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando IMDX +8.80% GlobeNewswire
Sep-08	Insight Molecular Diagnostics Announces Positive Strategic Update and Novel Registry Database IMDX GlobeNewswire
Sep-08	IMDX Enrolls First Patient in GraftAssureDx Clinical Trial and Welcomes New Hospital Participants IMDX GlobeNewswire
Aug-26	iMDx to Participate in NYC Investment Conferences September 8 - 11 IMDX GlobeNewswire
Aug-11	IMDX Reports Q2 2025 Results and Momentum Toward GraftAssureDx Launch IMDX GlobeNewswire
Aug-04	iMDx to Release Second Quarter 2025 Results on August 11, 2025 and Attend Needham Virtual MedTech and Diagnostics Conference IMDX +8.20% IMDX -5.78% GlobeNewswire
Jul-30	IMDX World Transplant Congress Late-Breaking Data Potentially Sets New Bar for Predicting Graft Rejection in Kidney Transplant Patients IMDX IMDX -6.67% GlobeNewswire
Jul-28	iMDx to Host Virtual KOL Event to Discuss its In-House dd-cfDNA Testing for Kidney Transplant Patients on August 15, 2025 IMDX GlobeNewswire
Jun-23	iMDx Reports Strong Head-to-Head Data in Kidney Transplant Rejection Testing IMDX -13.68% IMDX -5.74% GlobeNewswire

Insight Molecular Diagnostics Inc.

Recent Articles by Insight Molecular Diagnostics Inc.

Upgrade your Finviz experience